Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should.
about
Consumption of Sutherlandia frutescens by HIV-Seropositive South African Adults: An Adaptive Double-Blind Randomized Placebo Controlled TrialIntegrating Community-Based Interventions to Reverse the Convergent TB/HIV Epidemics in Rural South AfricaCost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South AfricaFactors associated with delayed entry into HIV medical care after HIV diagnosis in a resource-limited setting: Data from a cohort study in India.Predictors of delayed antiretroviral therapy initiation, mortality, and loss to followup in HIV infected patients eligible for HIV treatment: data from an HIV cohort study in India.HIV self-testing and the missing linkage.Diagnostic point-of-care tests in resource-limited settingsLinkage to HIV care and antiretroviral therapy by HIV testing service type in Central Mozambique: a retrospective cohort study.Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India.Impact of geographic and transportation-related barriers on HIV outcomes in sub-Saharan Africa: a systematic review.Patients present earlier and survival has improved, but pre-ART attrition is high in a six-year HIV cohort data from Ethiopia.Population-level reduction in adult mortality after extension of free anti-retroviral therapy provision into rural areas in northern Malawi.The cost-effectiveness of different feeding patterns combined with prompt treatments for preventing mother-to-child HIV transmission in South Africa: estimates from simulation modeling.Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review.Comparative effectiveness of HIV testing and treatment in highly endemic regions.Stigmatising attitudes among people offered home-based HIV testing and counselling in Blantyre, Malawi: construction and analysis of a stigma scale.High rate of loss to clinical follow up among African HIV-infected patients attending a London clinic: a retrospective analysis of a clinical cohort.The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.Rethinking the "pre" in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs.Determinants and consequences of failure of linkage to antiretroviral therapy at primary care level in Blantyre, Malawi: a prospective cohort study.Routine HIV testing in adolescents and young adults presenting to an outpatient clinic in Durban, South AfricaImproving HIV outcomes in resource-limited countries: the importance of quality indicators.Early loss to follow-up of recently diagnosed HIV-infected adults from routine pre-ART care in a rural district hospital in Kenya: a cohort studyRisk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South Africa.Factors associated with self-reported repeat HIV testing after a negative result in Durban, South Africa.Evidence of improving antiretroviral therapy treatment delays: an analysis of eight years of programmatic outcomes in Blantyre, MalawiA randomized trial to optimize HIV/TB care in South Africa: design of the Sizanani trial.Predictors of loss to follow-up before HIV treatment initiation in Northwest Ethiopia: a case control study.Modeling the implementation of universal coverage for HIV treatment as prevention and its impact on the HIV epidemic.HIV treatment for preventionAn augmented SMS intervention to improve access to antenatal CD4 testing and ART initiation in HIV-infected pregnant women: a cluster randomized trialHIV testing rates, prevalence, and knowledge among outpatients in Durban, South Africa: Time trends over four yearsA single-blind randomized controlled trial to evaluate the effect of extended counseling on uptake of pre-antiretroviral care in Eastern UgandaUnderstanding treatment refusal among adults presenting for HIV-testing in Soweto, South Africa: a qualitative study.Barriers to antiretroviral initiation in HIV-1-discordant couples.Introduction and evaluation of a 'pre-ART care' service in Swaziland: an operational research studyThe Missing Men: HIV Treatment Scale-Up and Life Expectancy in Sub-Saharan Africa.The Link4Health study to evaluate the effectiveness of a combination intervention strategy for linkage to and retention in HIV care in Swaziland: protocol for a cluster randomized trialTrends in CD4 Count Testing, Retention in Pre-ART Care, and ART Initiation Rates over the First Decade of Expansion of HIV Services in Haiti.Individual and Population Level Impact of Key HIV Risk Factors on HIV Incidence Rates in Durban, South Africa.
P2860
Q28546632-D7728D65-F670-4D9B-BC8E-D620F41577E7Q28547001-36B05650-DD2A-4267-8D8C-1AF268FC7643Q28554655-E623FC07-6ED2-41BB-9977-AFB974672E0AQ30651715-06125065-E009-4046-BFDD-0EE22637DF82Q30704115-587BEE3D-74FB-4EA8-B616-FB1EB84B8055Q31032212-3329B06F-4994-4552-8DA3-1CBCAA16E611Q33590492-3127BA6F-34DC-40E2-933F-C30AF59D318AQ33610797-BC8AD11E-313C-48F3-9AA1-8D8A1636372AQ33700455-D0BF3F24-E383-43EE-AE69-1903A29E908FQ33717359-96725712-9C3E-4ADC-803F-95B66F2A3AD3Q33719226-96BE4E64-ED0F-40AE-949D-E0215765B5D4Q33728235-BE5EFC8D-47E7-4362-86E7-ACE2C23A7576Q33940190-78FE69CE-2448-41D4-9882-602267F11294Q33979497-0F4FC661-48EE-46F3-8B38-8B508FF36EE7Q34064269-FA1ACDAF-B924-44BF-8BDD-6249DD50D6D0Q34064710-541AE045-AA11-4A03-B2D2-B4A08389D9E7Q34075017-DEFE7ACD-379E-4B59-99C1-405FBEF746CFQ34195493-815E204B-6E18-4775-B705-E5D1B1B2FD03Q34326620-2624B83C-493E-46E3-B4F2-E41B8BFEAE36Q34416119-5585C6CA-F32A-4D3D-98B9-EC29EB3F4CC1Q34429246-611F6324-5AC4-437A-8F64-C52307348619Q34487057-4DE0E43E-5D00-47A9-9270-D2D00690DD57Q34503222-D665F636-A0A2-4C30-8FCD-6B34717EDC87Q34576363-F7E47F3D-7D2A-4B74-ACD4-4CAA68EEC8C9Q34693048-60843EF5-8349-43B9-BAD7-F51D1C666B67Q34728761-B03C7954-BC25-4B4D-BFF4-21EFB35AB776Q34968268-C15AF20F-7292-4291-927B-AB7B4558312EQ34993198-AB78B760-896D-4265-A176-952B5BD35A6EQ34993280-B7EBAD77-2B13-4E3C-88EB-6F9B39957A6EQ35069410-D7DE7AFA-8E78-4E5A-8F1E-A8C01DE85D32Q35101541-EA436E8E-7BDC-4687-B5A3-5875BE1F2596Q35185951-08040CCD-4612-4E0B-B880-714DC7DD0D44Q35207829-6C57E2D6-7A96-413F-BEF3-79639923AF31Q35370765-D78BE05D-BF33-4CB5-A595-7EDEB8D4412DQ35452737-C1236C2A-5E41-4956-81BF-C071AFD76303Q35838211-0EDB91A3-D068-47D4-836A-839DE7832BEBQ35850422-7E13F46E-11C7-4D2B-AD41-81CDE38A424DQ35864187-26C2F94D-899B-42A3-838D-A89511C7CA05Q35931409-B71500DD-49EA-4DAB-A714-D4E9A3D4E672Q35996904-192FF3D6-4BFA-4958-B5E3-3A9CA9F10317
P2860
Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should.
@ast
Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should.
@en
type
label
Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should.
@ast
Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should.
@en
prefLabel
Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should.
@ast
Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should.
@en
P2093
P2860
P50
P1433
P1476
Who starts antiretroviral therapy in Durban, South Africa?... not everyone who should.
@en
P2093
Helga Holst
Jeffrey N Katz
Lauren M Uhler
Senica Chetty
P2860
P304
P356
10.1097/01.AIDS.0000366081.91192.1C
P407
P478
24 Suppl 1
P50
P577
2010-01-01T00:00:00Z